Browse 1,662 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Endometrial cancer, which starts in the lining of the uterus, is the most common gynecologic cancer in the United States and one of the few cancers whose death rate has been rising. The most common early warning sign is bleeding after menopause, which is why it is often found early and treated with surgery. Research matters most for cancer that returns or has spread, where immunotherapy combined with chemotherapy became a standard first treatment only in the past few years, and trials are testing new targeted drugs matched to the tumor's genetic profile.
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
for
Cancer, Breast Cancer, Lung Cancer, Colon Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT03702309
Recruiting
Active & Responsive
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
for
Rare Disorders, Undiagnosed Disorders,
Location: Sioux Falls SD
Sponsor: Sanford Health
Sex: All
Age: 0+
Code: NCT01793168
Recruiting
Active & Responsive
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
for
Cervical Cancer, Uterine Cancer, Endometrial Cancer
Location: Voorhees Township NJ, Philadelphia PA, Lancaster PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: Female
Age: 18+
Code: NCT05758688
Phase 2, Recruiting
Active & Responsive
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
for
Cascade Testing, Lynch Syndrome, Decision Making,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT07106359
Recruiting
Active & Responsive
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Genital Neoplasm, Female,
Location: Boston MA, Bethesda MD, Toronto, Celebration FL,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05592626
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase 1, Phase 2, Recruiting
Active & ResponsiveNew
This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors
Location: Boston MA, New Haven CT, Lake Success NY, New York NY,
Sponsor: Pheast Therapeutics
Sex: All
Age: 18+
Code: NCT06840886
Phase 1, Recruiting
Active & Responsive
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Upland CA, Irvine CA, Lancaster CA, Duarte CA,
Sponsor: City of Hope Medical Center
Sex: Female
Age: 18+
Code: NCT07741968
Recruiting
Active & Responsive
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
for
Lung Cancer (Diagnosis), Osteochondroma, Spitz Nevus,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT07675967
Recruiting
Active & Responsive
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,
Location: Boston MA, Fairfax VA, Orlando FL, Cleveland OH,
Sponsor: Terremoto Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07109726
Phase 1, Phase 2, Recruiting
Active & Responsive
Met Non Small Cell Cancer Registry (MOMENT)
for
Cancer
Location: Quebec, Ottawa, Fort Lauderdale FL, Toronto,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 0+
Code: NCT05376891
Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
for
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Boston MA, New York NY, Fairfax VA, Durham NC,